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Abstract
Background: Large linked databases (LLDB) represent a novel resource for cancer outcomes research. However, accurate 
means of identifying a patient population of interest within these LLDBs can be challenging. Our research group developed 
a fully integrated platform that provides a means of combining independent legacy databases into a single cancer-focused 
LLDB system. We compared the sensitivity and speciﬁ  city of several SQL-based query strategies for identifying a histo-
logic lymphoma subtype in this LLDB to determine the most accurate legacy data source for identifying a speciﬁ  c cancer 
patient population. 
Methods: Query strategies were developed to identify patients with follicular lymphoma from a LLDB of cancer registry 
data, electronic medical records (EMR), laboratory, administrative, pharmacy, and other clinical data. Queries were performed 
using common diagnostic codes (ICD-9), cancer registry histology codes (ICD-O), and text searches of EMRs. We reviewed 
medical records and pathology reports to conﬁ  rm each diagnosis and calculated the sensitivity and speciﬁ  city for each 
query strategy.
Results: Together the queries identiﬁ  ed 1538 potential cases of follicular lymphoma. Review of pathology and other 
medical reports conﬁ  rmed 415 cases of follicular lymphoma, 300 pathology-veriﬁ  ed and 115 veriﬁ  ed from other medical 
reports. The query using ICD-O codes was highly speciﬁ  c (96%). Queries using text strings varied in sensitivity 
(range 7–92%) and speciﬁ  city (range 86–99%). Queries using ICD-9 codes were both less sensitive (34–44%) and speciﬁ  c 
(35–87%). 
Conclusions: Queries of linked-cancer databases that include cancer registry data should utilize ICD-O codes or employ 
structured free-text searches to identify patient populations with a precise histologic diagnosis.
Keywords: Large linked database, cancer outcomes research, cancer epidemiology, cancer registry
Abbreviations: LLDB: Large Linked Database; SEER: Surveillance Epidemiology and End Results; EMR: Electronic 
Medical Record; ICD-9: International Classiﬁ  cation of Diseases (9th revision); ICD-O: International Classiﬁ  cation of 
Diseases for Oncology; AP: Anatomical Pathology; WHO: World Health Organization.
Background 
Linking legacy clinical and administrative databases provides a novel resource for investigating cancer 
risk factors and predictors of clinical outcomes. However, using large linked databases (LLDB) for 
medical research purposes is limited by several factors. First, reliance upon coded outcomes such as 
International Classiﬁ  cation of Diseases, Ninth Revision (ICD-9) diagnosis codes can lead to signiﬁ  cant 
inaccuracies (Benesch et al. 1997; Guevara et al. 1999; Rosamond et al. 2004; Verstraeten et al. 2003). 
ICD-9 provides a classiﬁ  cation system for assigning codes to diagnoses and procedures associated with 
healthcare utilization, but frequently are assigned by personnel unfamiliar with the patient, disease or 
procedure being coded. Second, the use of patient identiﬁ  ers such as social security numbers to link 
data across heterogeneous databases can lead to data integrity problems caused by data entry errors, 
incomplete data entry, or inconsistent practices such as entering a mother’s social security number for 
a child whose identiﬁ  er is not available (Graiser et al. 2005d). Third, some LLDBs capture identical 
data points from multiple sources which compound the inaccuracies unique to each data source. Users Cancer Informatics 2007:3 150
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of query tools for searching LLDBs need the most 
effective search strategies for identifying relevant 
information, if these data are to be used to perform 
meaningful clinical and epidemiological research 
(Koroukian et al. 2003; McClish et al. 1997; 
Warren and Harlan, 2003; Benesch et al. 1997).
GeneSys SI represents a LLDB that is a fully 
integrated platform combining clinical, administra-
tive, and genetic databases to allow researchers to 
simultaneously query multiple source databases 
and therefore facilitate cancer outcomes research 
(Graiser et al. 2005b). Rather than replacing 
existing databases and systems, this platform is 
designed to interface with an institution’s existing 
databases to create a stand-alone SQL-based, data 
warehouse that can be readily accessed by 
researchers. GeneSys SI was jointly developed 
through a partnership between Emory University’s 
Winship Cancer Institute and NuTec Health 
Systems to link data for 180,000 oncology patients 
including data from legacy administrative (Health-
Quest: hospital; IDX: clinic), cancer registry 
(IMPAC Medical Systems), electronic medical 
records (Cerner PowerChart), laboratory, pharmacy, 
clinical trials databases as well as newly developed 
genomics and microarray databases. The source 
systems feeding the LLDB independently store the 
following diagnosis data: cancer registry Interna-
tional Classification of Diseases for Oncology 
(ICD-O) topography and histology codes (a SEER 
standard format), three sources of ICD-9 diagnosis 
codes from the hospital, clinic, and radiation 
oncology, and electronic medical record reports 
such a physician notes and pathology reports. A 
summary of data sources is shown in Table 1. The 
system architecture is illustrated in Figure 1. The 
linked database runs under Microsoft Windows 
2000 Server Operating System on an Intel(R) 
XEON(TM) 2.20GHz-based CPU system with 
2048 Mbytes of RAM and 471101 Mbytes of total 
hard disk space. The system has a redundant IBM 
Workstation/Server with an external tape backup 
subsystem. Physically, the servers are protected by 
both key-card access as well as key access and   
monitored by security camera to maintain personal 
health information in a manner that is compliant 
with Health Insurance Portability and Account-
ability Act of 1996 (HIPAA) standards. 
When using LLDB systems for clinical and epide-
miologic research, numerous options exist for 
performing queries to identify patients with a diag-
nosis of interest. Queries can be based on different 
sources of diagnostic information, different query 
strategies or combinations of sources and search 
strategies (Rector et al. 2004). In the future, additional 
modiﬁ  cation to search strategies utilizing a method 
based on the hidden Markov chain may facilitate 
searching genomic databases (Smith et al. 2003). The 
availability of diagnosis data from numerous sources 
accentuates the need to ascertain the best method for 
identifying patients with a speciﬁ  c histologic diag-
nosis, since these sources can potentially yield 
different results depending on the query. The linked 
Medicare-SEER database represents a large linked 
administrative dataset that is frequently used in 
clinical and epidemiologic research. Several studies 
have examined strategies to identify diagnoses of 
interest with a focus on the use of ICD-9 codes. Many 
of these studies conclude that case-identiﬁ  cation 
strategies based on ICD-9 codes remain inadequate 
(Barzilai et al. 2004, Cooper et al. 1999a, Rolnick 
et al. 2004, Warren et al. 1999).
We designed and tested database search strategies 
to identify a cohort of patients with follicular 
lymphoma using the above-mentioned heteroge-
neous data sources. While other investigators have 
examined strategies for identifying patients with 
cancer at a particular site (Nattinger et al. 2004; 
Rolnick et al. 2004; Warren et al. 1999), cases of 
follicular lymphoma were selected as a suitable 
Table 1. GeneSys SI sources databases and start dates 
for source data.
DATA SOURCE  STARTING DATE
DATA WAREHOUSE
 Hospital  administrative  1995
 (HealthQuest)
 Clinic  administrative  (IDX)  1994
 Medical  Records  1987
 Clinical  Labs  2001
 Hospital  Pharmacy  1998
 Clinic  Pharmacy  2002
CANCER REGISTRY
 Emory  Hospital  1977
  Crawford Long Hospital  1981
CLINICAL TRIALS  1981
ELECTRONIC MEDICAL   1991
RECORD (Cerner PowerChart) 
RADIATION ONCOLOGY
  The Emory Clinic  1994
  Crawford Long Hospital  2001
GENOMICS 2004
 (data  structures) 
FORMS 2003
 (e.g.  informed  consent) Cancer Informatics 2007:3 151
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study population since this represents a histologic 
diagnosis that is important to distinguish from other 
forms of non-Hodgkin lymphoma and frequently 
can be misclassiﬁ  ed in administrative datasets. The 
ability of each search strategy to correctly identify 
patients with follicular lymphoma was examined to 
determine the most sensitive and speciﬁ  c search 
strategy. The aim of this study was to use follicular 
lymphoma as a challenging diagnosis to identify 
with computer search methods in order to determine 
‘best practices’ recommendations for developing 
search strategies in cancer-focused LLDB systems, 
such as SEER linked to administrative datasets.
Methods
Queries
We utilized a series of search strategies to identify a 
joint population of interest containing potential 
patients with follicular lymphoma and then sought to 
ascertain their histologic diagnosis by reviewing 
pathology reports. An initial population originated 
from a list of 817 patients supplied from the Emory 
University Cancer Registry database (MRS Cancer 
Registry, IMPAC Medical Systems, Inc., Cambridge, 
MA). This source provides SEER data for the Atlanta 
registry. The population was derived from an existing 
list of non-Hodgkin lymphoma patients from 1985–
2002. We used the social security number as the 
patient identiﬁ  er. A data scrubbing process using 
the social security number was performed to obtain 
the medical record numbers needed to query 
GeneSys SI. This reduced the list to 783 patients 
of whom 425 were found in the LLDB. This popu-
lation (labeled QCR in Table 2) was selected to 
enrich the ﬁ  nal population with cases of follicular 
lymphoma in the event that all query strategies 
yielded few patients with this diagnosis. 
In our ﬁ  rst query, we searched the LLDB using 
cancer registry histology codes to identify follicular 
lymphoma patients. The following SEER ICD-O 
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morphology codes were selected: 9690 (follicular 
lymphoma, NOS), 9695 (follicular lymphoma, 
grade 1), 9691(follicular lymphoma, grade 2), 9698 
(follicular lymphoma, grade 3) (Percy et al. 2000). 
The query also included the ICD-O behavior code 
3 (malignant neoplasms, primary). This query is 
labeled Q1 in Tables and Figures.
The next series of queries involved text searches 
of the electronic medical records. Each text string 
search was conducted twice, once limited to 
anatomical pathology (AP) reports, and once 
accessing all medical records. The electronic 
medical records of a sample of the Q1 population 
were examined to develop a list of text string 
candidates. The phrase ‘follicular lymphoma’ was 
determined to be the most promising phrase. To 
support our aims to establish sensitive search strat-
egies, a query using the UMLS Metathesaurus 
Concept Search was performed to obtain synonyms 
for follicular lymphoma (2006). This revealed 51 
synonyms for follicular lymphoma. We identiﬁ  ed 
21 terms that had histologic overlap with the World 
Health Organization definition for follicular 
lymphoma and would not have been included by 
other queries (e.g. “Malignant lymphoma, centro-
blastic-centrocytic, follicular” would have been 
found by the text query “follicular” NEAR 
“lymphoma”). Ultimately, ﬁ  ve phrases from the 
UMLS synonym list were incorporated into two 
queries. Refer to Table 3 for a list of the synonym 
phrases examined and the ﬁ  nal content of the 
queries from this list. Due to observed variations 
in the appearance of the words ‘follicular’ and 
‘lymphoma’, documents were searched for a) the 
occurrence of the phrase ‘follicular lymphoma’ and 
b) the occurrence of the word ‘follicular’ near the 
word ‘lymphoma’. The NEAR function was used 
to search for each term using a ﬁ  xed algorithm of 
searching within 50 words in either direction of 
the other term. The six text string document 
searches are labeled queries Q2, Q3, Q4, Q5, Q11 
and Q12.
Table 2. Queries to identify follicular lymphoma cases within a linked legacy database.
QUERY SOURCE  CRITERIA  RECORDS
     IDENTIFIED
      (% of all records)
QCR  Imported list from Cancer  Follicular lymphoma by
  Registry  histology codes, 1985–2002  425 (28%)
Q1  Cancer Registry, ICD-O   Morphology codes 9690, 9691, 
  morphology codes   9695, 9698 plus behavior  242 (16%)
  plus behavior code 3  code 3
 (malignant,  primary)
Q2  Text search–pathology reports  ‘follicular’ NEAR ‘lymphoma’  406 (26%)
Q3  Text search–pathology reports  ‘follicular lymphoma’  126 (8%)
Q4  Text search–all medical record 
  reports  ‘follicular’ NEAR ‘lymphoma’  531 (35%)
Q5  Test search–all medical record 
 reports  ‘follicular  lymphoma’  193  (13%)
Q6  ICD-9 codes–Emory Clinic  202.0, 202.00, 202.01, 
    202.02, 202.03, 202.04,  901 (59%)
   202.05,  202.06,  202.07, 
   202.08 
Q7  ICD-9 codes–Emory Hospitals  (same as Q6 above)  288 (19%)
Q8  Q2 + Q6  (see criteria for Q2 and 
    Q6 above)  1137 (74%)
Q9  Q4 + Q6   (see criteria for Q4 and 
    Q6 above)  1233 (80%)
Q10  Q1 + Q2  (see criteria for Q1 and 
    Q2 above)  498 (32%)
Q11  Text search–pathology reports  (UMLS terms–see Table 3)   36 (2%)
Q12  Text search–all medical record  
  reports  (UMLS terms–see Table 3)  121 (8%)
  Total cases reviewed combining 
 all  queries    1538Cancer Informatics 2007:3 153
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ICD-9 diagnosis codes in the linked database 
system were supplied by the administrative 
systems for the Emory University Hospitals and 
The Emory Clinic. The Emory University Hospi-
tals utilize the HealthQuest system (McKeeson 
Information Solutions, Inc., Alpharetta, GA) while 
The Emory Clinic uses the IDX system (IDX 
Systems Corporation, Burlington, VT). The poten-
tial ICD-9 codes that could be utilized in coding 
follicular lymphoma, including both unspeciﬁ  ed 
and site-speciﬁ  c disease, include ten codes in the 
range of 202.0–202.08. The query strategy using 
ICD-9 codes from the clinic was labeled Q6 and 
that using ICD-9 codes derived from the hospital 
system was labeled Q7.
In an effort to deﬁ  ne search strategies with 
improved sensitivity, combination search strategies 
were designed. Joining Q2 and Q6 utilized a 
combination of a medical records strategy and an 
administrative query (Q8). Joining Q4 and Q6 
accomplished the same goal with the broader (and 
potentially more sensitive) search of all medical 
records (Q9). Combining queries of cancer registry 
and free text of pathology reports with speciﬁ  ed 
terms (believed to be the two most speciﬁ  c strate-
gies a priori) was performed to establish a highly 
speciﬁ  c and highly sensitive search strategy.
Conﬁ  rmation of histiologic diagnosis
To conﬁ  rm a diagnosis of follicular lymphoma, the 
medical records of all patients were examined. For 
each patient, pathology reports were reviewed to 
confirm histologic cancer diagnosis. When 
pathology reports were unable to conﬁ  rm or refute 
a diagnosis of follicular lymphoma, the electronic 
medical record was reviewed to identify other chart 
evidence (e.g. physician notes) to conﬁ  rm a diag-
nosis, which could result in a chart-veriﬁ  ed diag-
nosis of follicular lymphoma. Diagnosis conﬁ  rma-
tion was complicated by non-uniform terminology 
on pathology reports resulting from the variation 
that has existed in lymphoma classiﬁ  cation strate-
gies over the past 20 years (Mauch et al. 2004). In 
all cases, World Health Organization (WHO) clas-
siﬁ  cation schema for non-Hodgkin lymphoma was 
utilized as the gold standard for diagnosis (Jaffe et 
al. 2001). A hematological oncologist (CF) resolved 
all cases where there was uncertainty as to whether 
the WHO criteria for follicular lymphoma were 
met. The disease-veriﬁ  ed status was then used to 
calculate the sensitivity and speciﬁ  city of each 
query strategy for detecting this histologic diag-
nosis in the LLDB. The total population of 1538 
patients found through the 13 queries was used in 
the calculations of sensitivity and speciﬁ  city. A 
receiver-operator plot was constructed to compare 
characteristics of the search strategies.
Results 
The ﬁ  rst query based on cancer registry histology 
codes (Q1) returned 242 patients. Searching 
pathology reports for the terms ‘follicular’ and 
‘lymphoma’ yielded 406 patients when the NEAR 
operator was used (Q2) and 126 patients when a 
text string was chosen (Q3). Free text searches of 
all medical records using the same search strategies 
found 531 patients with the use of the NEAR 
operator (Q4) and 193 patients when the terms 
were combined (Q5). The queries using additional 
phrases from the UMLS synonym list retrieved 
relatively few patients (36 and 121 for Q11 and 
Q12, respectively), only 18 of whom were unique 
to the entire study population of 1538. Nine 
hundred and one patients were found associated 
with potential ICD-9 codes for follicular lymphoma 
Table 3. Description of text queries based on UMLS 
synonyms for follicular lymphoma.
Selected UMLS synonyms  RECORDS 
 IDENTIFIED
  (% of all records 
 reviewed)
“nodular lymphoma”  75 (5%)
“Brill–Symmers” 0
“Brill–Symmers” 0
“reticulosarcoma–follicular” 0
“reticulosarcoma–nodular” 0
“follicular lymphosarcoma”  0
“giant follicular lymphoma”  0
“mal.lym,centr-blas/cyt,foll” 0
“malig.lymphoma, nodular”  0
“malig. lymphoma, nodular”  0
“lymphoma, nodular”  65 (4%)
“nodular lymphosarcoma”  0
“follicle center lymphoma”  13 (<1%)
“follicular non-Hodgkin”  35 (2.3%)
“foll low grade B-cell lymphoma”  0
“germinoblastoma, follicular”  0
“lymphoma, follicle center”  4 (<1%)
“malignant lymphoma, 
lymphocytic, nodular”  0
“lyoma,centrbl-centrcyt,foll” 0
“reticulosarcoma, follicular”  0
“reticulosarcoma, nodular”  0Cancer Informatics 2007:3 154
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(Q6) from electronic medical records. A smaller 
group of 288 patients was retrieved with these 
ICD-9 codes from hospital diagnosis records (Q7). 
Combining results from Q2 and Q6 retrieved 1137 
patients (Q8). Combining populations from Q4 and 
Q6 yielded 1233 patients (Q9). A combination of 
results in queries Q1 and Q2 gave a combined 
population of 498 (Q10). Together the thirteen 
query populations resulted in 1538 unique patients. 
All query results are summarized in Table 2.
The results of disease conﬁ  rmation, sensitivity, 
and speciﬁ  city for each query strategy are summa-
rized in Table 4. Queries that utilized SEER 
histology codes (Q1), text searches of electronic 
medical record reports for the term ‘follicular 
lymphoma’ (Q3, Q5), and terms from the UMLS 
synonym list (Q11, Q12) had the greatest patho-
logical-confirmed specificity, 97.4%, 96.5%, 
99.0% and 95.7% respectively. Query strategies 
that used the NEAR operator in free-text searches 
(Q2, Q4, Q8, Q9, Q10) had higher sensitivity for 
identifying cases of follicular lymphoma, 89.7%, 
93.0%, 93.3%, 95.3%, and 95.0% respectively. 
Queries using free-text searches of pathology 
records (Q2, Q3) identiﬁ  ed fewer cases of follic-
ular lymphoma without marked improvements in 
speciﬁ  city when compared with similar free-text 
searches of all medical records (Q4, Q5). The 
queries using the NEAR operator in free-text 
searches alone (Q2, Q4) or in combination with 
cancer registry histology codes (Q10) yielded the 
most favorable search strategy characteristics. 
False positive results commonly occurred in free 
text searches due to the inclusion of the phrase of 
interesting in text discussing a differential diag-
nosis or diagnosis that had been ruled out. A 
receiver-operator plot (Figure 2) shows an upper-
left quadrant clustering of queries Q2, Q4, and 
Q10 representing those that simultaneously maxi-
mized sensitivity and specificity. Combining 
SEER ICD-O histology codes with a free text 
search of pathology reports using the NEAR 
operator provided the most favorable character-
istics with a sensitivity of 95% and a speciﬁ  city 
of 85% and identiﬁ  ed 337 of 415 cases of follic-
ular lymphoma present in this dataset.
Discussion 
We examined a series of query strategies designed 
to identify patients with a histologic diagnosis of 
follicular lymphoma in a cancer information 
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system composed of linked, heterogeneous, legacy 
databases. Our findings indicate that free-text 
search strategies of electronic medical records and 
subpopulations of the medical record, such as 
pathology notes, can provide accurate methods to 
identify patients with a histologic cancer diagnosis. 
These query strategies were comparable to a query 
on coded entries for cancer histology by ICD-O 
codes in the linked subset of the Emory University 
cancer registry, a source dataset for the Atlanta 
SEER database. 
Although this study is limited by its focus on 
a single disease entity, our results suggest that 
free-text searches of electronic medical records 
can provide an accurate means of identifying 
populations of interest. Text searches of electronic 
medical records may allow for greater accuracy 
for disease identiﬁ  cation but require experimen-
tation to determine the best search strings to 
employ. A search of the UMLS Knowledge Source 
Server can be performed to ensure that additional 
possibilities for describing a particular disease 
are included in the text string search. Searches 
using UMLS-derived phrases other than “follic-
ular lymphoma”, while highly speciﬁ  c, identiﬁ  ed 
few additional patients. Other coded medical 
vocabularies potentially may provide more accu-
rate means for identifying sub-populations with 
a particular pathological diagnosis, but these are 
rarely present in legacy data systems where the 
majority of patient data exists. However, terms 
from vocabularies such as the Systematized 
Nomenclature of Medicine (SNOMED) or the 
Medical Entities Dictionary (MED) could also be 
employed to identify additional terms for free-text 
searches.
Queries that utilized the free-text search strategy 
for ‘follicular lymphoma’ in across all document 
had high sensitivity and speciﬁ  city likely due to the 
mention of this term in chart notes and pathology 
reports for these patients. When examining the six 
queries of document searches, limiting the search 
Figure 2. Receiver-operator plot of query strategies to identify a pathology-conﬁ  rmed histologic diagnosis of follicular lymphoma
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to pathology reports appears to have marginally 
improved specificity. Similarly, searching the 
phrase ‘follicular lymphoma’ was more accurate 
than using the NEAR function to search for ‘follic-
ular’ within a ﬁ  xed distance of 50 words from the 
word ‘lymphoma’. These broader searches increase 
sensitivity but decrease speciﬁ  city. Future modiﬁ  ca-
tions to the free-text search strategies such as 
varying the proximity parameter for the NEAR 
operator or allowing for fuzzy matching may 
continue to improve this methodology. Our results 
also indicate that combination queries tend to 
increase sensitivity at the expense of lowering 
speciﬁ  city. However, judicious use of combination 
queries may allow for expansion of cohort popula-
tions with limited effects on speciﬁ  city.
Search strategies that utilized cancer registry 
diagnosis information (ICD-O codes) yield similar 
sensitivity and speciﬁ  city as that of text searches 
of electronic medical records, but identify fewer 
overall cancer cases. This is likely due to the high 
degree of coding accuracy of the cancer registrars, 
and the presence of patients with follicular 
lymphoma treated at the cancer center that did not 
meet criteria for entry in the registry. In ongoing 
research studies on prostate cancer (Graiser et al. 
2005c) and hepatocellular carcinoma (Graiser et 
al. 2005a), we also observed that cancer registry 
codes and structured free-text queries provide 
improved means for identifying subpopulations of 
patients with a particular cancer diagnosis. 
However, cancer registry diagnostic data provide 
a more efﬁ  cient source for obtaining accurate 
patient disease identiﬁ  cation.
The ICD-O is used broadly in United States by 
cancer registry systems including SEER for coding 
the site (topography) and the histology (morphology) 
of neoplasms, with a separate one-digit code 
provided for histologic grading or differentiation. 
The ICD-O has been published English, Flemish/
Dutch, German, Japanese, Korean, Romanian, and 
Turkish and has translations in development for 
several other languages. In contrast, ICD-9 codes, 
which are used extensively in health care data-
bases, typically mix description of the site and type 
of neoplasm. Moreover, the greater accuracy in 
ICD-O over ICD-9 codes may also be due to the 
fact that the cancer registry data is annotated and 
entered by professionals abstracting patient cases 
from a thorough review of the patient’s medical 
records as compared to ICD-9 codes that may be 
entered by billing clerks who may not collect these 
additional data. However, reliance on ICD-O codes 
may produce inaccuracies due changes in disease 
classiﬁ  cation schema over time, inter-observer 
differences in classification, and may provide 
incomplete information on cancer morphology, 
sub-site, and behavior. (Clarke et al. 2004; Glaser 
et al. 2001; Castillo et al. 2004; Patriarca et al. 
2001) Nevertheless, for complex diagnostic entities 
like the non-Hodgkin lymphomas, ICD-O codes 
currently provide the best means in common prac-
tice for classifying clinically-relevant, histologic 
subsets of cancer. ICD-O codes also remain the 
basis for estimating population trends in cancer 
incidence and identifying new risk factors for 
cancer (Groves et al. 2000; Morton et al. 2006).
As seen in our study, query strategies based on 
ICD-O codes are more useful than searches based 
on ICD-9 codes. This is a reasonable search 
strategy for cancer-related LLDBs since most 
cancer registry systems, including the SEER data-
base, already collect these data. Although not 
reported externally, many health care systems also 
have internal tumor registries that collect ICD-O 
codes in their database. Despite the availability of 
ICD-O codes in cancer registry databases, most 
clinical and epidemiologic studies using LLDBs 
continue to rely on ICD-9 diagnostic codes.
Previous studies utilizing linked databases, 
including Medicare, Medicaid, SEER, HMO, and 
other administrative sources, have evaluated the 
use of ICD-9 diagnostic codes for case identiﬁ  ca-
tion. Most of these studies have found signiﬁ  cant 
discordance between ICD-9 diagnosis codes from 
Medicare claims and cancer registry data (McClish 
et al. 1997; Benesch et al. 1997; Schrag et al. 2002). 
Our study conﬁ  rms the low sensitivity and speci-
ficity of ICD-9 diagnosis codes for providing 
precise histologic diagnosis information, and high-
lights the need for more accurate means of case 
identiﬁ  cation if LLDBs are to be used for outcomes 
research. Moreover, our ﬁ  ndings validate the ﬁ  nd-
ings of epidemiological studies based on ICD-O 
diagnoses (Groves et al. 2000; Morton et al. 2006), 
and corroborate other researchers who have chal-
lenged the use of ICD-9 codes for cancer outcomes 
research (Koroukian et al. 2003; McClish et al. 
1997; Warren et al. 2002).
Conclusion
As electronic medical records systems and methods 
of linking these systems to other clinical and admin-Cancer Informatics 2007:3 157
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istrative databases become more widespread, devel-
oping methods to utilize these linkages for clinical 
and epidemiologic research will become increas-
ingly important (Cooper et al. 1999b). Currently, 
large-linked databases containing patient-speciﬁ  c 
administrative data are used for cancer outcomes 
research and bioinformatics research. Clearly delin-
eated methods for identifying subjects with a histo-
logic diagnosis of cancer are needed in order for 
biologically-relevant conclusions to be drawn from 
analyses of these data. Moreover, as linked-legacy 
databases are increasingly being used to by academic 
centers to identify patients for cancer biomarker 
studies, biologically-targeted therapies, genomics, 
and other research endeavors, methods to identify 
patients with a histologic diagnosis rather than a 
clinical diagnosis become even more important. Our 
work provides a ﬁ  rst step toward this aim, utilizing 
a challenging histologic diagnosis that is often 
misclassiﬁ  ed in clinical and administrative datasets. 
Future research using linked-cancer databases for 
studies that focus on a population with a precise 
histologic diagnosis may beneﬁ  t from case identi-
ﬁ  cation procedures that are based on ICD-O or 
include structured free text search strategies. Addi-
tional studies are ongoing to conﬁ  rm these ﬁ  ndings 
for other cancer diagnoses.
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